Arch Therapeutics (ARTH)
OTHER OTC:ARTH
Holding ARTH?
Track your performance easily

Arch Therapeutics (ARTH) Financial Statements

162 Followers

Arch Therapeutics Financial Overview

Arch Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.856; its P/E ratio is -0.10; Arch Therapeutics is scheduled to report earnings on May 14, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue$ 30.91K$ 31.87K$ 45.87K$ 13.29K$ 16.65K
Gross Profit$ 9.83K$ 10.31K$ 22.26K$ -5.24K$ -2.06K
EBIT$ -5.65M$ -876.74K$ -1.49M$ -1.82M$ -267.29K
EBITDA$ -5.65M$ -876.18K$ -1.49M$ -1.82M$ -266.91K
Net Income Common Stockholders$ -6.38M$ -1.47M$ -2.68M$ -1.82M$ -902.48K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 30.03K$ 26.43K$ 205.85K$ 86.54K$ 29.50K
Total Assets$ 1.40M$ 1.54M$ 1.82M$ 1.56M$ 1.59M
Total Debt$ 0.00$ 0.00$ 0.00$ 690.01K$ 0.00
Net Debt$ -30.03K$ -26.43K$ -205.85K$ 603.47K$ -29.50K
Total Liabilities$ 4.57M$ 4.36M$ 4.12M$ 9.58M$ 3.51M
Stockholders Equity$ -12.56M$ -10.88M$ -9.58M$ -8.02M$ -6.39M
Cash Flow-
Free Cash Flow$ -911.64K$ -700.16K$ -862.61K$ -897.55K$ -599.87K
Operating Cash Flow$ -911.64K$ -700.16K$ -862.61K$ -897.55K$ -599.87K
Investing Cash Flow-----
Financing Cash Flow$ 915.25K$ 520.74K$ 845.74K$ 954.60K$ 618.74K
Currency in USD

Arch Therapeutics Earnings and Revenue History

Arch Therapeutics Debt to Assets

Arch Therapeutics Cash Flow

Arch Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis